TABLE OF CONTENTS
Volume 14, Issue 4 (April 2007)
Original Articles
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via 
6-integrins
M Stevenson, A B H Hale, S J Hale, N K Green, G Black, K D Fisher, K Ulbrich, A Fabra and L W Seymour
Cancer Gene Ther 14: 335-345; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701022
Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells
Y Tang, P Borgstrom, J Maynard, J Koziol, Z Hu, A Garen and A Deisseroth
Cancer Gene Ther 14: 346-353; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701030
Local delivery system of cytotoxic agents to tumors by focused sonoporation
K Iwanaga, K Tominaga, K Yamamoto, M Habu, H Maeda, S Akifusa, T Tsujisawa, T Okinaga, J Fukuda and T Nishihara
Cancer Gene Ther 14: 354-363; advance online publication, February 2, 2007; doi:10.1038/sj.cgt.7701026
Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection
J C Solheim, A J Reber, A E Ashour, S Robinson, M Futakuchi, S G Kurz, K Hood, R R Fields, L R Shafer, D Cornell, S Sutjipto, S Zurawski, D M LaFace, R K Singh and J E Talmadge
Cancer Gene Ther 14: 364-371; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701018
The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon
antitumor therapy
M Van Roy, B Wielockx, A Baker and C Libert
Cancer Gene Ther 14: 372-379; advance online publication, January 12, 2007; doi:10.1038/sj.cgt.7701020
Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA 
anti-CD3 diabodies from lentivirally transduced human lymphocytes
M Compte, B Blanco, F Serrano, Á M Cuesta, L Sanz, A Bernad, P Holliger and L Álvarez-Vallina
Cancer Gene Ther 14: 380-388; advance online publication, January 12, 2007; doi:10.1038/sj.cgt.7701021
New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice
I O-Sullivan, A Chopra, T S Kim, S Magnuson, M T Falduto, J Huang and E P Cohen
Cancer Gene Ther 14: 389-398; advance online publication, February 2, 2007; doi:10.1038/sj.cgt.7701023
A conditionally replicative, Wnt/
-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer
P H Abbosh, X Li, L Li, T A Gardner, C Kao and K P Nephew
Cancer Gene Ther 14: 399-408; advance online publication, January 12, 2007; doi:10.1038/sj.cgt.7701024
Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
T Chan, Z Chen, S Hao, S Xu, J Yuan, A Saxena, M Qureshi, C Zheng and J Xiang
Cancer Gene Ther 14: 409-420; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701025
A three-dimensional assay for measurement of viral-induced oncolysis
J T Lam, A Hemminki, A Kanerva, K B Lee, J L Blackwell, R Desmond, G P Siegal and D T Curiel
Cancer Gene Ther 14: 421-430; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701028
The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells
J Neukirchen, A Meier, A Rohrbeck, G Garcia-Pardillos, U Steidl, R Fenk, R Haas, R Kronenwett and U-P Rohr
Cancer Gene Ther 14: 431-439; advance online publication, January 19, 2007; doi:10.1038/sj.cgt.7701029
Corrigenda
Gene therapy of liver tumors with human liver-specific nanoparticles FREE
M Ueda, Y Iwasaki, T Yamada, A Kondo, M Seno, K Tanizawa, S Kuroda, M Sakamoto and M Kitajima
Cancer Gene Ther 14: 440; doi:10.1038/sj.cgt.7701031
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer FREE
E Frau, C Magnon, P Opolon, E Connault, D Opolon, F Beermann, M Abitbol, M Perricaudet and C Bouquet
Cancer Gene Ther 14: 440; doi:10.1038/sj.cgt.7701032
